- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/10 - SulfuresSulfoxydesSulfones
Détention brevets de la classe A61K 31/10
Brevets de cette classe: 876
Historique des publications depuis 10 ans
|
62
|
60
|
60
|
87
|
74
|
58
|
70
|
56
|
58
|
25
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The Regents of the University of California | 19839 |
13 |
| Onconova Therapeutics, Inc. | 45 |
13 |
| Action Medicines, S.L. | 15 |
8 |
| Peloton Therapeutics, Inc. | 37 |
8 |
| The University of British Columbia | 1495 |
8 |
| Olatec Therapeutics, Inc. | 61 |
8 |
| The Cleveland Clinic Foundation | 1574 |
7 |
| Temple University of the Commonwealth System of Higher Education | 607 |
7 |
| Sanofi | 4021 |
7 |
| The Procter & Gamble Company | 22050 |
6 |
| British Columbia Cancer Agency Branch | 192 |
6 |
| Livionex Inc. | 11 |
6 |
| Olatec Industries LLC | 11 |
6 |
| Olatec Therapeutics LLC | 26 |
6 |
| Genentech, Inc. | 3968 |
5 |
| Allergan, Inc. | 2361 |
5 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2145 |
5 |
| Case Western Reserve University | 1804 |
5 |
| National Institute of Biological Sciences, Beijing | 97 |
5 |
| Pronova Biopharma Norge AS | 64 |
5 |
| Autres propriétaires | 737 |